Bruker Corporation

Healthcare · Medical Devices

64.20$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Bruker Corporation (BRKR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 839 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BRKR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	394	470	385	415	436	531	432	444	467	554	461	490	521	600	424	425	511	628	555	571	609	684	595	588	639	708	685	682	743	855	722	801	864	980	801	797	861	977	823	839	3,500
Cost of Revenue	209	250	209	232	238	275	232	239	244	281	247	260	267	302	231	242	262	312	275	290	300	340	288	289	304	343	326	341	360	424	369	416	446	486	410	440	481	528	434	423	1,866
Gross Profit	185	220	176	183	198	255	199	205	223	273	215	230	254	298	193	183	249	316	280	281	309	344	307	300	335	366	360	341	383	430	353	385	419	493	391	358	379	449	389	416	1,634
Research & Development	38	38	38	41	41	44	43	44	42	45	46	49	46	47	49	44	48	57	55	56	52	58	57	60	56	64	69	71	71	84	82	92	98	104	97	100	98	100	101	94	394
Selling, General & Administrative	97	100	98	103	103	112	110	111	107	117	120	125	126	133	125	104	115	133	132	135	141	157	146	153	145	168	163	178	178	212	195	221	239	237	225	225	243	247	242	239	971
Total Operating Expenses	135	138	136	144	144	156	154	154	148	162	167	173	171	177	177	143	168	188	191	195	196	212	210	226	201	235	237	254	258	327	288	337	351	421	359	346	344	337	344	481	1,507
Operating Income	46	77	38	34	50	94	38	49	69	106	42	54	88	120	16	40	81	128	89	86	113	132	97	74	135	131	123	86	125	104	65	48	68	72	32	12	35	112	45	-65	127
Interest Expense	3.4	3.8	3.7	3.8	3.6	4.3	3.4	2.6	2.3	4.3	3.1	3.7	4.7	3.2	1.9	2.7	3.9	2.6	3.8	5.6	4.4	0.4	4.1	4.0	3.7	3.2	7.2	3.9	3.9	4.4	5.0	16	12	16	13	16	20	11	12	18	62
Pre-Tax Income	43	88	32	30	47	89	36	43	65	100	38	48	83	111	14	31	75	106	85	80	109	120	94	70	130	122	107	78	120	242	72	24	55	55	26	1.1	-73	67	18	-41	-28
Income Tax Expense	-4.0	19	9.9	6.2	9.8	92	8.4	12	21	22	7.7	11	22	42	2.9	7.1	20	34	28	21	21	44	32	20	41	23	30	20	31	37	20	16	15	41	8.7	-3.1	-14	38	2.5	14	40
Net Income	47	69	22	23	37	-3.4	27	31	43	78	31	37	61	69	11	24	54	69	57	58	87	76	62	50	88	97	77	57	88	206	51	7.6	41	14	17	7.6	-60	26	14	-52	-71
EBITDA	60	101	53	56	72	118	58	65	88	125	67	75	100	133	38	53	106	130	115	111	137	143	124	107	150	160	139	107	150	283	111	85	118	125	89	72	4.2	138	89	17	248

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings